ANTI-COVID19: Functional protective antibody determinants during and after SARS-CoV-2 (and other CoV) infection to define and predict individual post- infection immunity, flock immunity and guide blood bank sero-treatment.
- Funded by UFM Denmark
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$516,160Funder
UFM DenmarkPrincipal Investigator
Professor Anders FomsgaardResearch Location
DenmarkLead Research Institution
Statens Serum InstitutResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
ImmunitySpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
The project concerns immunity, hereunder the possibility to examine specific antibodies generated by COVID-19 patients during and after the disease (both severe and mild cases). The project aims to examine whether those antibodies produced in patients during COVID-19 may boost immunity in new patients or patients in risk groups and in this way support the treatment of the next wave of COVID patients